It refers to retatrutide, a tripleagonist weightloss medication that activates GLP1, GIP, and glucagon receptors. Early clinical trials show unprecedented weightloss results, often greater than currently approved GLP1 and dualagonist drugs, along with improvements in liver fat and metabolic markers. As research advances and more data become available, medically supervised programs will continue to evaluate where TRIPLEagonist medications fit among GLP1 drugs, dualagonists, peptides, and other tools for sustainable metabolic health
The longer answer is that GLP-1 medications interact with several hormonal systems in ways that are generally positive rather than disruptive, though the effects vary between individuals and are worth understanding
So now were no longer talking adults, we might start being able to treat overweight kids with this drug
The GLP-1 hormone regulates appetite and blood sugar levels after food intake
She is a resident doctor, researcher, and medical writer who believes in the importance of accessible, quality healthcare for everyone